Search

Treatment of acute lymphoblastic leukemia by activation of patient's immune cells by a bispecific antibody.

Jun 13 2014 Posted in Press releases

Abstract S722
Acute lymphoblastic leukemia (ALL) is a rare type of blood cancer which is mainly treated by intensive chemotherapy.

COVID-19 – Impact on Childhood Hematology Patients

Wolfs, Tom F. W.

SWG Educational Activities

EICMLThe 2023 EICML meeting took place in Naples in May 2023. Fifty-five physicians and scientists met at the Palazzo Alabardieri in central Naples to spend two days discussing emerging data and developing collaborations.

Program

Saturday, June 15, 2024 - Presidential Session I

Conducting multinational RCTs in pregnancy to improve maternal health in thrombosis: it CAN be done

Prof. Saskia Middeldorp, The Netherlands

Targeting the epigenome in lymphoma

Prof.

FDA Reports of Secondary Malignancies Following Chimeric Antigen Receptor (CAR) T Cell Therapies and Relative Risk: an EBMT-EHA-GoCART Coalition Statement

Dec 13 2023

We need to bring your attention to the recent warning disseminated by the Food and Drug Administration (FDA) regarding T-cell lymphomas in patients undergoing Chimeric Antigen Receptor T-cell (CAR-T) therapy (1).

SWG Educational Activities

EHA-SWG meetingsAn EMSCO meeting was held in October 2023 (Nice, France).

EHA collaborates with THD to provide critical aid to hematologists

Jun 23 2023 Posted in Press releases Tagged THD, support, earthquake, Türkiye

The Hague (Netherlands), June 23, 2023. The European Hematology Association (EHA) is proud to announce its partnership with the Türk Hematoloji Derneği (THD) in a joint effort to support hematologists working in earthquake-affected areas in Türkiye and Syria.